Alexandria Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-74
| Closed | -$11K | – | 519 |
|
|
2017
Q3 | $11K | Buy |
74
+4
| +6% | +$595 | ﹤0.01% | 411 |
|
|
2017
Q2 | $9K | Buy |
70
+9
| +15% | +$1.16K | ﹤0.01% | 438 |
|
|
2017
Q1 | $7K | Buy |
61
+5
| +9% | +$574 | ﹤0.01% | 463 |
|
|
2016
Q4 | $4K | Buy |
56
+9
| +19% | +$643 | ﹤0.01% | 502 |
|
|
2016
Q3 | $4K | Buy |
47
+7
| +18% | +$596 | ﹤0.01% | 515 |
|
|
2016
Q2 | $3K | Buy |
40
+6
| +18% | +$450 | ﹤0.01% | 533 |
|
|
2016
Q1 | $3K | Buy |
34
+18
| +113% | +$1.59K | ﹤0.01% | 540 |
|
|
2015
Q4 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 602 |
|
|
2014
Q3 | – | Sell |
-29
| Closed | -$3K | – | 592 |
|
|
2014
Q2 | $3K | Sell |
29
-21
| -42% | -$2.17K | ﹤0.01% | 511 |
|
|
2014
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 489 |
|
|
2013
Q4 | $4K | Sell |
50
-27
| -35% | -$2.16K | ﹤0.01% | 500 |
|
|
2013
Q3 | $6K | Buy |
77
+7
| +10% | +$545 | ﹤0.01% | 437 |
|
|
2013
Q2 | $6K | Buy |
+70
| New | +$6K | ﹤0.01% | 460 |
|